Evidence map›Paper›PMID 36862646›Full record

ArticlePloS one2023

Prevalence and correlates of prescription opioid use among US adults, 2019-2020.

Anna Zajacova, Hanna Grol-Prokopczyk, Merita Limani, Christopher Schwarz, Ian Gilron

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Safety Assessment of Perioperative Pain Medications for Children: Variation in Opioid Prescribing at Discharge.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotype.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Anna ZajacovaDepartment of Sociology, University of Western Ontario, London, Ontario, Canada.ORCID 0000-0002-3880-6187
Hanna Grol-ProkopczykDepartment of Sociology, University at Buffalo, State University of New York, Buffalo, New York, United States of America.ORCID 0000-0002-3270-637X
Merita LimaniDepartment of Sociology, University of Western Ontario, London, Ontario, Canada.
Christopher SchwarzDepartment of Politics, New York University, New York, New York, United States of America.
Ian GilronDepartment of Anesthesiology and Perioperative Medicine, Queen's University School of Medicine, Kingston, Ontario, Canada.
Western University · CANew York University · USQueen's University · CAUniversity at Buffalo, State University of New York · US

Funding

Educational Attainment, Geography, and U.S. Adult Mortality RiskR01AG055481 · NIA · SYRACUSE UNIVERSITY · PI MONTEZ, JENNIFER KARAS · 2017 to 2021
$1.7M
The Demography of Chronic Pain: A Population Approach to Pain Trends, Pain Disparities, and Pain-Related Disability and DeathR01AG065351 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GROL-PROKOPCZYK, HANNA · 2020 to 2024
$1.5M
NIA NIH HHS R01 AG055481NIA NIH HHS R01 AG065351
6 · The paper itself

Abstract

This study estimates the prevalence of prescription opioid use (POU) in the United States (US) in 2019-2020, both in the general population and specifically among adults with pain. It also identifies key geographic, demographic, and socioeconomic correlates of POU. Data were from the nationally-representative National Health Interview Survey 2019 and 2020 (N = 52,617). We estimated POU prevalence in the prior 12 months among all adults (18+), adults with chronic pain (CP), and adults with high-impact chronic pain (HICP). Modified Poisson regression models estimated POU patterns across covariates. We found POU prevalence of 11.9% (95% CI 11.5, 12.3) in the general population, 29.3% (95% CI 28.2, 30.4) among those with CP, and 41.2% (95% CI 39.2, 43.2) among those with HICP. Findings from fully-adjusted models include the following: In the general population, POU prevalence declined about 9% from 2019 to 2020 (PR = 0.91, 95% CI 0.85, 0.96). POU varied substantially across US geographic regions: It was significantly more common in the Midwest, West, and especially the South, where adults had 40% higher POU (PR = 1.40, 95% CI 1.26, 1.55) than in the Northeast. In contrast, there were no differences by rural/urban residence. In terms of individual characteristics, POU was lowest among immigrants and among the uninsured, and was highest among adults who were food insecure and/or not employed. These findings suggest that prescription opioid use remains high among American adults, especially those with pain. Geographic patterns suggest systemic differences in therapeutic regimes across regions but not rurality, while patterns across social characteristics highlight the complex, opposing effects of limited access to care and socioeconomic precarity. Against the backdrop of continuing debates about benefits and risks of opioid analgesics, this study identifies and invites further research about geographic regions and social groups with particularly high or low prescription opioid use.

Indexed as

Chronic PainOpioid-Related DisordersAdultAnalgesics, OpioidHumansPrescriptionsPrevalenceAnalgesics, Opioid

Identifiers

PMID36862646
PMCPMC9980762
OpenAlexW4322757870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.